TY - JOUR
T1 - Reference values for fluorine-18-fluorodeoxyglucose and fluorine-18-sodium fluoride uptake in human arteries
T2 - a prospective evaluation of 89 healthy adults
AU - Blomberg, Bjørn
AU - Thomassen, Anders
AU - de Jong, Pim A
AU - Lam, Marnix G E H
AU - Hess, Søren
AU - Olsen, Michael H
AU - Mali, Willem P T M
AU - Alavi, Abass
AU - Høilund-Carlsen, Poul F.
N1 - Publisher Copyright:
Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.
PY - 2017
Y1 - 2017
N2 - Objective Reference values of fluorine-18-fluorodeoxyglucose (
18F-FDG) and fluorine-18-sodium fluoride (
18F-NaF) uptake in human arteries are unknown. The aim of this study was to determine age-specific and sex-specific reference values of arterial
18F-FDG and
18F-NaF uptake. Participants and methods Uptake of
18F-FDG and
18F-NaF was determined in the ascending aorta, aortic arch, and descending thoracic aorta. In addition,
18F-FDG uptake was determined in the carotid arteries and
18F-NaF uptake was determined in the coronary arteries. Arterial
18F-FDG and
18F-NaF uptake were quantified as the blood pool subtracted maximum activity concentration in kBq/ml (BS
18F-FDG
max and BS
18F-NaF
max, respectively). In addition to determining reference values, we evaluated the influence of age and sex on BS
18F-FDG
max and BS
18F-NaF
max. Results Arterial
18F-FDG and
18F-NaF uptake was assessed in 89 healthy adults aged 21-75 years (mean age: 44±14 years, 53% men). Both BS
18F-FDG
max and BS
18F-NaF
max increased with age. BS
18F-FDG
max increased with age in the descending aorta (β=0.28; P=0.003), whereas BS
18F-NaF
max increased with age in the ascending aorta (β=0.18; P<0.001), aortic arch (β=0.19; P=0.006), descending aorta (β=0.33; P<0.001), and coronary arteries (β=0.20; P=0.009), respectively. BS
18F-FDG
max and BS
18F-NaF
max were not influenced by sex, except for BS
18F-FDG
max in the ascending aorta. Conclusion Prospective evaluation of 89 healthy adults generated age-specific and sex-specific reference values of arterial
18F-FDG and
18F-NaF uptake. Our findings indicate that arterial
18F-FDG and
18F-NaF uptake tend to increase with age.
AB - Objective Reference values of fluorine-18-fluorodeoxyglucose (
18F-FDG) and fluorine-18-sodium fluoride (
18F-NaF) uptake in human arteries are unknown. The aim of this study was to determine age-specific and sex-specific reference values of arterial
18F-FDG and
18F-NaF uptake. Participants and methods Uptake of
18F-FDG and
18F-NaF was determined in the ascending aorta, aortic arch, and descending thoracic aorta. In addition,
18F-FDG uptake was determined in the carotid arteries and
18F-NaF uptake was determined in the coronary arteries. Arterial
18F-FDG and
18F-NaF uptake were quantified as the blood pool subtracted maximum activity concentration in kBq/ml (BS
18F-FDG
max and BS
18F-NaF
max, respectively). In addition to determining reference values, we evaluated the influence of age and sex on BS
18F-FDG
max and BS
18F-NaF
max. Results Arterial
18F-FDG and
18F-NaF uptake was assessed in 89 healthy adults aged 21-75 years (mean age: 44±14 years, 53% men). Both BS
18F-FDG
max and BS
18F-NaF
max increased with age. BS
18F-FDG
max increased with age in the descending aorta (β=0.28; P=0.003), whereas BS
18F-NaF
max increased with age in the ascending aorta (β=0.18; P<0.001), aortic arch (β=0.19; P=0.006), descending aorta (β=0.33; P<0.001), and coronary arteries (β=0.20; P=0.009), respectively. BS
18F-FDG
max and BS
18F-NaF
max were not influenced by sex, except for BS
18F-FDG
max in the ascending aorta. Conclusion Prospective evaluation of 89 healthy adults generated age-specific and sex-specific reference values of arterial
18F-FDG and
18F-NaF uptake. Our findings indicate that arterial
18F-FDG and
18F-NaF uptake tend to increase with age.
KW - PET/CT
KW - fluorine-18-sodium fluoride
KW - reference values
KW - vascular calcification
KW - atherosclerosis
KW - fluorine-18-fluorodeoxyglucose
UR - http://www.scopus.com/inward/record.url?scp=85032221676&partnerID=8YFLogxK
U2 - 10.1097/MNM.0000000000000748
DO - 10.1097/MNM.0000000000000748
M3 - Article
C2 - 28902094
SN - 0143-3636
VL - 38
SP - 998
EP - 1006
JO - Nuclear Medicine Communications
JF - Nuclear Medicine Communications
IS - 11
ER -